Documents
Application Sponsors
ANDA 207449 | FRESENIUS KABI USA | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 50MG/ML | 0 | DEXTROSE 5% IN PLASTIC CONTAINER | DEXTROSE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2016-10-21 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2018-06-26 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 14 | AP | 2020-11-20 | UNKNOWN |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 19 | AP | 2022-07-20 | UNKNOWN |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 3 | Null | 15 |
SUPPL | 14 | Null | 15 |
SUPPL | 19 | Null | 7 |
TE Codes
CDER Filings
FRESENIUS KABI USA
cder:Array
(
[0] => Array
(
[ApplNo] => 207449
[companyName] => FRESENIUS KABI USA
[docInserts] => ["",""]
[products] => [{"drugName":"DEXTROSE 5% IN PLASTIC CONTAINER","activeIngredients":"DEXTROSE","strength":"50MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/21\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/207449Orig1s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"10\/21\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/207449Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/207449Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] => [{"actionDate":"06\/26\/2018","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2018-06-26
)
)